Decreased expression of pigment epithelium derived factor (PEDF), an inhibitor of angiogenesis, in placentas of unexplained stillbirths

Reproductive Biology

Volumn 8, Issue 2, 2008, Pages 107-120

  Plunkett, Beth A ^a   Fitchev, Philip ^a   Doll, Jennifer A ^a   Gerber, Susan E ^a   Cornwell, Mona ^a   Greenstein, Emily P ^a   Crawford, Susan E ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Angiogenesis; PEDF; Placenta; Stillbirth

Indexed keywords

ANGIOGENESIS INHIBITOR; EYE PROTEIN; NERVE GROWTH FACTOR; PIGMENT EPITHELIUM DERIVED FACTOR; PIGMENT EPITHELIUM-DERIVED FACTOR; SERINE PROTEINASE INHIBITOR;

ADULT; ARTICLE; BIOSYNTHESIS; FEMALE; GESTATIONAL AGE; HUMAN; METABOLISM; PATHOLOGY; PLACENTA; PREGNANCY; STILLBIRTH;

ADULT; ANGIOGENESIS INHIBITORS; EYE PROTEINS; FEMALE; GESTATIONAL AGE; HUMANS; NERVE GROWTH FACTORS; PLACENTA; PREGNANCY; SERPINS; STILLBIRTH;

EID: 54449100925     PISSN: 1642431X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1642-431X(12)60007-2     Document Type: Article

References (27)

1. Alexander GR, Himes JH, Kaufman RB, Mor J, Kogan M 1996 A United States national reference for fetal growth. Obstetrics and Gynecology 87 163-168.
2. Charlock-Jones DS, Kaufmann P, Mayhew TM 2004 Aspects of human fetoplacental vasculogenesis and angiogenesis. I. Molecular Regulation. Placenta 25 103-113.
3. Clark DE, Smith SK, Licence D, Evans AL, Charnock-Jones DS 1998 Comparison of expression patterns for placenta growth factor, vascular endothelial growth factor (VEGF), VEGF-B and VEGF-C in the human placenta throughout gestation. Journal of Endocrinology 159 459-467.
4. Cleaver O, Melton DA 2003 Endothelial signaling during development. Nature Medicine 9 661-668.
5. th edition. W. B. Saunders Company, Philadelphia, PA.
6. Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H, Benedict W, Bouck NP 1999 Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 285 245-248.
7. Doll JA, Stellmach VM, Bouck NP, Bergh AR, Lee C, Abramson LP, Cornwell ML, Pins MR, Borensztajn J, Crawford SE 2003 Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas. Nature Medicine 9 774-780.
8. Ferarra N, Gerber H-P, LeCouter J 2003 The biology of VEGF and its receptors. Nature Medicine 9 669-676.
9. Fok RY, Pavlova Z, Benirschke K, Paul RH, Platt LD 1990 The correlation of arterial lesions with umbilical artery Doppler velocimetry in the placentas of small-for-dates pregnancies. Obstetrics and Gynecology 75 578-583.
10. Freeman AF, Crawford SE, Cornwall ML, Garcia FL, Shulman ST, Rowley AH 2005 Angiogenesis in fatal acute Kawasaki disease coronary artery and myocardium. Pediatric Cardiology 26 578-584.
11. Genest DR 1992 Estimating the time of death in stillborn fetuses: II. Histologic evaluation of the placenta; A study of 71 stillborns. Obstetrics and Gynecology 4 585-592.
12. Gerber H-P, Hillan KJ, Ryan AM, Kowalski J, Keller G-A, Rangell L, Wright BD, Radtke F, Aguet M, Ferrara N 1999 VEGF is required for growth and survival in neonatal mice. Development 126 1149-1159.
13. Heath D, Edwards JE 1958 The pathology of hypertensive pulmonary vascular disease: a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects. Circulation 18 533-547.
14. Kaufmann P, Mayhew TM, Charnock-Jones DS 2004 Aspects of human fetoplacental vasculogenesis and angiogenesis. II. Changes during normal pregnancy. Placenta 25 114-126.
15. Liu H, Ren JG, Cooper WL, Hawkins CE, Cowan MR, Tong PY 2004 Identification of the antivasopermeability effect of pigment epithelium-derived factor and its active site. Proceedings of the National Academy of Sciences of the USA 101 6605-6610.
16. Ong S, Lash G, Baker PN 2000 Angiogenesis and placental growth in normal and compromised pregnancies. Baillieres Best Practice and Research. Clinical Obstetrics and Gynecology 14 969-980.
17. Owen J, Stedman CM, Tucker TL 1989 Comparison of predelivery versus post delivery Kleihauer-Betke stains in cases of fetal death. American Journal of Obstetrics and Gynecology 161 666-669.
18. Redline RW, Ariel I, Baergen RN, DeSa DJ, Kraus FT, Roberts DJ, Sander CM 2004 Fetal vascular obstructive lesions: nosology and reproducibility of placental reaction patterns. Pediatric and Developmental Pathology 7 443-452.
19. Sherer DM, Abulafia O 2001 Angiogenesis during implantation, and placental and early embryonic development. Placenta 22 1-13.
20. Taylor RN, Grimwood J, Taylor RS, McMaster MT, Fisher SJ, North RA 2003 Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies. American Journal of Obstetrics and Gynecology 188 177-182.
21. Tombran-Tink J, Mazuruk K, Rodriguez IR, Chung D, Linker T, Englander E, Chader GJ 1996 Organization, evolutionary conservation, expression and unusual Alu density of the human gene for pigment epithelium-derived factor, a unique neurotrophic serpin. Molecular Vision 2 11.
22. Trollman R, Amann K, Schoof E, Beinder E, Wenzel D, Rascher W, Dotsch J 2003 Hypoxia activates the human placental vascular endothelial growth factor system in vitro and in vivo: up-regulation of vascular endothelial growth factor in clinically relevant hypoxic ischemia in birth asphyxia. American Journal of Obstetrics and Gynecology 188 517-523.
23. Villasante A, Pacheco A, Ruiz A, Pellicer A, Garcia-Velasco JA 2007 Vascular endothelial cadherin regulates vascular permeability: implications for ovarian hyperstimulation syndrome. Journal of Clinical Endocrinology and Metabolism 92 314-321.
24. Weiner CP 1990 The relationship between the umbilical artery systolic/diastolic ratio and umbilical blood gas measurements in specimens obtained by co cordocentesis. American Journal of Obstetrics and Gynecology 162 1198-1202.
25. Yamagishi S, Nakamura K, Matsui T, Inagaki Y, Takenaka K, Jinnouchi Y, Matsuura T, Narama I, Motomiya Y, Takeuchi M, Inoue H, Yoshimura A, Bucala R, Imaizumi T 2006 Pigment epithelium-derived factor inhibits advanced glycation end-product induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression. Journal of Biology and Chemistry 281 20213-20220.
26. Zhang SX, Wang JJ, Gao G, Parke K, Ma JX 2006 Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy. Journal of Molecular Endocrinology 37 1-12.
27. Zhao Q, Ishibashi M, Hiasa K-I, Tan C, Takeshita A, Egashira K 2004 Essential role of vascular endothelial growth factor in angiotensin II-induced vascular inflammation and remodeling. Hypertension 44 264-270.